Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TOREMIFENE CITRATE, with a corresponding US DMF Number 28770.
Remarkably, this DMF maintains an Active status since its submission on October 16, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2016, and payment made on July 16, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II